InterLabService – Advanced Technology for Molecular Diagnostics

Dear colleagues and partners!

Please accept our  sincere congratulations and warm wishes for the upcoming Christmas and New Year!
Together we have achieved a lot, but much remains to be done.
May every coming day of 2020 be filled with success, and the next year will make it possible to carry out the most ambitious plans.
We wish you good health, happiness and family harmony!
Sincerely, InterLabService

Our scientific group which specializes on STI studies has recently published tree articles on Florocenosis disorder syndromes.

Tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) is the deadliest infectious disease more often appears in Central Asia, Eastern Europe and Russia and the associated global threat has worsened with the emergence of drug resistance, in particular multidrug resistant TB (MDR-TB).

It is known that the incidence of respiratory tract infections such as cold and influenza show seasonal fluctuations and the peaks of respiratory illness occur in winter months. Around 33% of the seasonal increase in mortality is associated with infectious respiratory disease, and there is evidence that some of the seasonal growth in mortality associated with cardiovascular disease may be related to respiratory infection. This winter seasonality in deaths and illnesses has been shown for over 200 respiratory pathogens. There is a distribution of infectious pathogens among different age groups in Russia.

New kits Amplisens® MAGNO-sorb-URO, Amplisens® DNA-sorb-D, Amplisens® Corynebacterium diphtheriae / tox-genes-FRT, Amplisens® Rickettsia conorii-FRT, Amplisens® Borrelia miyamotoi-FRT, AmpliSens® Yellow fever virus-FRT and Amplisens® FiloA-screen-FRT are available now in InterLabService company.